These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 14529054
21. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma. Banov CH, Howland WC, Lumry WR. Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734 [Abstract] [Full Text] [Related]
22. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B. Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813 [Abstract] [Full Text] [Related]
23. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE. J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706 [Abstract] [Full Text] [Related]
24. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma. Karpel J, D'urzo A, Lockey RF. J Asthma; 2008 Nov; 45(9):747-53. PubMed ID: 18972289 [Abstract] [Full Text] [Related]
27. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma. Zeidler M, Corren J, Tashkin DP. Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376 [Abstract] [Full Text] [Related]
28. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetzky M, Kemp JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipane GA, Wanderer A, Cuss FM, Nolop KB, Harrison JE. Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973 [Abstract] [Full Text] [Related]
29. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study. Krouse JH, Krouse HJ, Janisse JJ. Clin Drug Investig; 2009 Sep; 29(1):51-8. PubMed ID: 19067474 [Abstract] [Full Text] [Related]
30. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212 [Abstract] [Full Text] [Related]
31. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings. Tohda Y, Miyamoto T. Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960 [Abstract] [Full Text] [Related]
32. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS. Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902 [Abstract] [Full Text] [Related]
33. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstätter R, Fabbri L. Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266 [Abstract] [Full Text] [Related]
36. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma. Karpel JP, Nelson H. Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978 [Abstract] [Full Text] [Related]
37. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L. Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199 [Abstract] [Full Text] [Related]